Deloitte’s UK Technology Fast 50 Awards open for nominations until 1 September
26th edition of the awards recognises the fastest growing technology companies in the UK.
Digital technologies that could revolutionise healthcare
From speech analytics and automation capabilities to deep learning platforms, there are many emerging digital technologies being used across industries to enhance customer experience.
NIHR IMID BioResource recruits its 10,000th volunteer in major milestone
The platform for research into Immune-Mediated Inflammatory Diseases (IMIDs) has now signed up 10,000 participants nationwide. Find out about the value of having such a large cohort and what it means for future research studies into IMIDs.
Prior’s robust ProScan® H117 stage enables long-term stability for hyperspatial spectroscopy and ultrafast microscopy applications
The Institute of Applied Physics at the Technische Universität Dresden is well known for its research into the physics of light. The study includes how light interacts with matter, the relationship between light and energy, and what we can learn from the properties of emerging classes of nanomaterials by observing light.
Meet DESI XS – Mass Spectrometry Imaging Case Study
Prior Scientific is known for developing and manufacturing cutting-edge microscope automation, working with OEMs and start-ups to help bring their concepts to market.
Prior Scientific to partner with NPL on third A4I-funded research project
Prior Scientific’s nanopositioning brand, Queensgate, has won funding in round 8 of Innovate UK’s Analysis for Innovation (A4I) program. This is their third successful application within the initiative.
The future of molecular diagnostics: divining the pathway
This decade, like few others in memory, has underscored the importance of molecular diagnostics both to individuals and to populations.
Metrion Biosciences announces launch of Good Laboratory Practice (GLP) hERG Screening Service
Metrion is now a member of the UK GLP (Good Laboratory Practice) Compliance Monitoring Programme New service with GLP certification further strengthens Metrion’s support for small molecule therapeutics developmentCambridge, UK, 01 August
Medical affairs evolution
Consultants from CRA’s Life Sciences Practice conducted a survey with n=50 leaders in Medical Affairs to learn from their perspectives on trends and challenges in the industry.
Global Access Diagnostics (GADx) reintroduces IT-Leish, the rapid diagnostic test for visceral leishmaniasis
London, UK - Global Access Diagnostics (GADx), a social enterprise prioritising equitable access to diagnostics, announces the launch of IT-Leish, a rapid diagnostic test (RDT) for visceral leishmaniasis (VL).
The power of contact lenses: drug delivery to the eye and more
Jaynell Ng, Graduate Electronics and Software Engineer, shares her experience living with Myopia and discusses how there is more to contact lenses than meets the eye.
electronRx moves to new premises to facilitate growth plans
Cambridge-based health tech company electronRx has moved into its new office within Compass House in Histon to facilitate its future expansion.
Class of 2023 SBC Catalyser Programme ‘graduate’ with flying colours
Ten startups at the intersection of therapeutics and techbio have celebrated completing Stevenage Bioscience Catalyst’s Catalyser Programme by pitching their ideas and commercialisation strategies to an audience of investors, experts and invited guests.
Occupational health consultation seeks to increase support for employers
The Government is seeking views on proposals aimed at increasing use of Occupational Health Services by UK employers.
Gyros Protein Technologies introduces PurePep EasyClean Auto Kit for automated parallel peptide purification
New automated kit overcomes major bottleneck in peptide production, providing optimized simultaneous workflows
Abzena appoints Thomas Castellano as Chief Financial Officer
Abzena, the leading end-to-end integrated CDMO for complex biologic molecules and Antibody Drug Conjugates (ADCs) has announced the appointment of Thomas Castellano, as Chief Financial Officer.
DLOC partners with 42 Technology to develop ‘human-on-chip’ system
DLOC Biosystems (DLOC), a spin-out from the American University of Beirut, has appointed 42 Technology (42T) as a strategic product development partner to help bring its advanced 3D human-on-chip technology and fully-automated operating system to market.
Qkine announces collaboration with Sartorius
Qkine, a manufacturer of animal-free, highly bioactive, and innovative proteins, announces its collaboration with Sartorius, a global life science group, to supply growth factors and cytokines for stem cell and organoid research, as part of a comprehensive workflow solution.
Camena Bioscience close $10 Series A financing as demand for DNA synthesis technology increases
Camena Bioscience, a synthetic biology company providing genes to the pharmaceutical and biotechnology industries, today announced it has closed a $10m Series A financing round, led by Mercia. The new funding will be used to scale operations and continue development of its pioneering DNA synthesis platform, gSynth™.
Elucidare receives award to develop spatial audio applications for mental health therapies
Elucidare, the commercialization and investment due diligence consultancy, announces the receipt of an award from Innovate UK for the development of spatial audio as a mental health therapy.
NK:IO raises £1.2M, bringing total Seed funding to £5.1M, to advance pioneering NK cell therapy
NK:IO, a leader in natural killer (NK) cell biology applied to the development of exceptionally potent, off-the-shelf cell therapies targeting solid tumours, has raised £1.2M.
D-CYPHR goes live across the UK
Largest ever DNA and health research programme for children and young people launches to tackle toughest health challenges – through the power of spit.
Qureight collaborates with AstraZeneca on lung disease research
Cambridge-based data analytics company Qureight has entered into a multi-year collaboration with biopharmaceutical company AstraZeneca.
Revvity establishes Scientific Centre of Excellence for Genomic Insight in Cambridge
Global health science solutions company Revvity, Inc., has announced the establishment of a Scientific Centre of Excellence in Cambridge, UK. Focused on driving genomic insights to accelerate therapeutic discovery, Revvity’s Scientific Centre of Excellence supports the Company’s fundamental commitment to expanding boundaries in pursuit of a better future for human health.